Europe Opioid Use Disorder Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$720.9

Forecast, 2030 (US$M)

$1,654.8

CAGR, 2024 - 2030

12.6%

Report Coverage

Europe

Europe opioid use disorder market, 2018-2030 (US$M)

Related Markets

Global Opioid Use Disorder Industry Outlook

North America Opioid Use Disorder Market Outlook

Asia Pacific Opioid Use Disorder Market Outlook

Latin America Opioid Use Disorder Market Outlook

MEA Opioid Use Disorder Market Outlook

Europe opioid use disorder market highlights

The Europe opioid use disorder market generated a revenue of USD 720.9 million in 2023.
The market is expected to grow at a CAGR of 12.6% from 2024 to 2030.
In terms of segment, buprenorphine was the largest revenue generating drug in 2023.
Buprenorphine is the most lucrative drug segment registering the fastest growth during the forecast period.

Europe data book summary

Market revenue in 2023	USD 720.9 million
Market revenue in 2030	USD 1,654.8 million
Growth rate	12.6% (CAGR from 2023 to 2030)
Largest segment	Buprenorphine
Fastest growing segment	Buprenorphine
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Buprenorphine
Key market players worldwide	Indivior PLC Ordinary Share, Alkermes PLC, Titan Pharmaceuticals Inc, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, MediciNova Inc, Orexo AB, Camurus AB, Omeros Corp

Other key industry trends

In terms of revenue, Europe region accounted for 15.7% of the global opioid use disorder market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 1,286.2 million by 2030.

Key Regions: UK , U.S. , Japan , Brazil , UAE

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Opioid Use Disorder Market Scope

Opioid use disorder market segmentation & scope

Drug

Buprenorphine

Sublocade

Belbuca

Suboxone

Zubsolv

Other Buprenorphine products

Methadone

Naltrexone

Others

Route of Administration

Oral Administration

Injectable Administration

Others

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Others

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Germany

France

Spain

Italy

Australia

China

Mexico

Denmark

Sweden

Norway

Japan

India

South Korea

Thailand

Brazil

Argentina

South Africa

Saudi Arabia

UAE

Kuwait

Opioid Use Disorder Market Companies

Name	Profile	# Employees	HQ	Website

Europe opioid use disorder market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to opioid use disorder market will help companies and investors design strategic landscapes.

Buprenorphine was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe opioid use disorder market based on buprenorphine covering the revenue growth of each sub-segment from 2018 to 2030.

Reasons to subscribe to Europe opioid use disorder market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe opioid use disorder market databook

Our clientele includes a mix of opioid use disorder market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe opioid use disorder market , including forecasts for subscribers. This continent databook contains high-level insights into Europe opioid use disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list